Pfizer Inc. (PFE)
Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Pfizer (PFE) stood at $24.70, denoting a +0.65% change from the preceding trading day.
PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters
Stocks of PFE, MRK, ABBV, LLY and others declined on Tuesday due to uncertainty surrounding Trump's proposed tariffs on pharma imports.
Proxy adviser ISS recommends Pfizer shareholders to vote against CEO compensation
Institutional Shareholder Services is recommending Pfizer's investors to reject a management proposal on annual compensation for CEO Albert Bourla and other executives, the proxy adviser said on Wednesday.
PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of age in the EU.
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease, the company said on Tuesday.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pfizer: Value Play or Past Its Prime?
Explore the exciting world of Pfizer (PFE -0.61%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here's What We Know.
Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported, bolstering a claim by President Donald Trump, who has claimed for years the company withheld vaccine results to impact his chances at reelection.
Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted.
Feds probe tip that Pfizer delayed announcing COVID vaccine's success until after 2020 election: report
The report said GSK's former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.
Here's Why Pfizer (PFE) Fell More Than Broader Market
In the latest trading session, Pfizer (PFE) closed at $25.21, marking a -1.33% move from the previous day.
US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports
Federal prosecutors in Manhattan are probing a claim brought by GSK that Pfizer delayed announcing the success of its COVID-19 vaccine in 2020 until after that year's election, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
